Table 1.
Baseline Details of each hospitalization by study phase and hospital service
| Gastroenterology/hospitalist service | P value | Other services | P value | |||
|---|---|---|---|---|---|---|
| Preintervention N = 184 | Postintervention N = 950 | Preintervention N = 914 | Postintervention N = 739 | |||
| Age (median yr, IQR) | 58 (51–65) | 58 (48–65) | 0.41 | 61 (53–68) | 61 (50–69) | 0.22 |
| Sex (female) | 105 (57%) | 478 (50%) | 0.11 | 539 (59%) | 437 (59%) | 0.99 |
| Private insurance | 90 (49%) | 501 (53%) | 0.40 | 443 (48%) | 382 (52%) | 0.17 |
| Alcohol-related cirrhosis | 74 (40%) | 471 (50%) | 0.02 | 351 (38%) | 335 (45%) | <0.01 |
| Hepatitis C | 17 (9.2%) | 87 (9.2%) | 1.00 | 118 (13%) | 94 (13%) | 0.97 |
| Ascites | 113 (61%) | 475 (50%) | <0.01 | 286 (31%) | 255 (35%) | 0.18 |
| Hepatic encephalopathy | 129 (70%) | 499 (53%) | <0.001 | 267 (29%) | 221 (30%) | 0.80 |
| Varices | 86 (47%) | 518 (55%) | 0.06 | 300 (33%) | 304 (41%) | <0.001 |
| HCC | 10 (5.4%) | 82 (8.6%) | 0.19 | 106 (12%) | 72 (9.7%) | 0.26 |
| MELD-Na (median, IQR) | 18 (13–25) | 18 (13–25) | 0.93 | 15 (11–20) | 16 (12–22) | <0.01 |
| Albumin (median g/dL, IQR) | 3.2 (2.8–3.6) | 3.2 (2.8–3.6) | 0.58 | 3.5 (3.0–3.9) | 3.3 (2.9–3.9) | 0.02 |
| Inhospital events | ||||||
| Paracentesis | 53 (29%) | 209 (22%) | 0.06 | 90 (9.8%) | 99 (13%) | 0.03 |
| SBP | 23 (13%) | 130 (14%) | 0.75 | 58 (6.3%) | 45 (6.1%) | 0.91 |
| TIPS | 3 (1.6%) | 40 (4.2%) | 0.14 | 22 (2.4%) | 45 (6.1%) | <0.001 |
| Dialysis | 0 | 2 (0.2%) | 1.00 | 1 (0.1%) | 4 (0.5%) | 0.25 |
| Endoscopy | 28 (15%) | 201 (21%) | 0.08 | 80 (8.8%) | 83 (11%) | 0.11 |
| Colonoscopy | 4 (2.2%) | 37 (3.9%) | 0.35 | 23 (2.5%) | 15 (2.0%) | 0.62 |
Other services include teaching services for internal medicine, surgery, cardiology, oncology, and others.
HCC, hepatocellular carcinoma; MELD-Na, model for end-stage liver disease–sodium; SBP, spontaneous bacterial peritonitis; TIPS, transjugular intrahepatic portosystemic shunt.